IDH1 and glioblastoma: Specchia et al. studied the correlation between 5-aminolevulinic acid (5-ALA) and the metabolic activity of glioblastoma multiforme (GBM) cells, and they found that the metabolic activity was more active in IDH wild-type tumors, while the metabolic activity of IDH-mutant tumors was lower [15].